Peringkat dalam Saham
#9438
Gubra A/S is a biotechnology firm engaged in two core activities: offering... Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
Harga Saham
$61.73
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$1.01B
Perubahan (1 hari)
-1.02%
Perubahan (1 tahun)
5.10%
Perdagangan Gubra A/S (GUBRA)
Harga GUBRA dengan kapitalisasi pasar B
Kapitalisasi pasar dari Gubra A/S(GUBRA)
Kapitalisasi Pasar: $1.01B
Per August 2026, Gubra A/S memiliki kapitalisasi pasar sebesar $1.01B. Ini menjadikan Gubra A/S sebagai perusahaan 9438th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Gubra A/S dari 2023 hingga 2026
GUBRA dibandingkan dengan 5 teratas stocks paling populer
| Harga GUBRA |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.264T
|
+519,247.75%
|
|
|
|
|
$4.701T
|
+463,740.88%
|
|
|
|
|
$4.177T
|
+412,031.91%
|
|
|
|
|
$3.817T
|
+376,535.35%
|
|
|
|
|
$2.866T
|
+282,700.72%
|
